Harmon Lab
Harmon Research Team
  • Our Mission
  • Dr. Harmon
  • People
  • Projects
  • Awards
  • Hall of Fame
  • Lab Abroad
  • Contact

Esophageal Cancer

  1. The severity of duodeno-esophageal reflux influences the development of different histological types of esophageal cancer in a rat model.
  2. Do proton pump inhibitors protect against cancer progression in GERD?
  3. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
  4. Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a post-Barrett's esophagus setting.
  5. Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a pre-Barrett's esophagus setting.
  6. Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model.
  7. Duodenal reflux leads to down regulation of DNA mismatch repair pathway in an animal model of esophageal cancer.
  8. Selective decrease in the DNA base excision repair pathway in squamous cell cancer of the esophagus.
  9. Elderly woman with hypercalcemia and neck mass.
  10. Epidermal growth factor receptor and hedgehog signaling pathways are active in esophageal cancer cells from rat reflux model.
  11. Duodenal reflux produces hyperproliferative epithelial esophagitis--a possible precursor to esophageal adenocarcinoma in the rat.